Literature DB >> 4395083

Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.

B J Alps, E S Johnson, A B Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4395083      PMCID: PMC1702669     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Autonomic blocking properties of Wy 21901.

Authors:  B J Alps; M Hill; E S Johnson; A B Wilson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

2.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04

3.  Controlled trial of propranolol in hypertension.

Authors:  F J Zacharias; K J Cowen
Journal:  Br Med J       Date:  1970-02-21
  3 in total
  8 in total

1.  Double blind controlled trial of indoramin in the treatment of essential hypertension.

Authors:  D T Dollery; D G George; P J Lewis
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

2.  Clinical evaluation of indoramin, a new antihypertensive agent.

Authors:  P J Lewis; C F George; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

3.  Autonomic blocking properties of Wy 21901.

Authors:  B J Alps; M Hill; E S Johnson; A B Wilson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

4.  Proceedings: Haemodynamic effects of indoramin: a non-invasive technique for the cardiovascular evaluation of drugs.

Authors:  D J Coltart; R B Royds
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

5.  Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.

Authors:  R B Royds
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

6.  Myocardial effects of indoramin hydrochloride, a new hypotensive agent.

Authors:  D J Coltart; S J Meldrum; R B Royds
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

7.  Pharmacokinetics of indoramin in man.

Authors:  G H Draffan; P J Lewis; J L Firmin; T W Jordan; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

8.  Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901).

Authors:  B J Alps; M Hill; E S Johnson; A B Wilson
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.